SuperCom Ltd. (NASDAQ: SPCB) Announces Extended Collaboration with Romanian Government Following Third $3.4 Million Order

 

• SuperCom, a global leading provider of traditional and digital identity solutions, just announced its latest order from the Romanian government to the tune of $3.4 million
• SuperCom will help Romania’s Ministry of Interior to bolster its EM project, based on its PureSecurity Suite, covering domestic violence monitoring, GPS tracking of offenders, as well as home detection monitoring
• Deliveries are set to be met by the end of Q4 2023, and SuperCom’s management is optimistic that the order will boost the company’s overall value proposition and lead to many more orders down the line

SuperCom (NASDAQ: SPCB), a leading global provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments, recently announced its continued collaboration with the Romanian government. The latest order from the country’s Ministry of Interior is part of an ongoing $30 million project, bolstering the country’s National Electronic Monitoring (“EM”) Project (https://ibn.fm/VALGi).

The EM program is based on SuperCom’s PureSecurity Suite, covering domestic violence monitoring, GPS tracking of offenders, and home detection monitoring. This end-to-end suite offers a secure real-time software platform. Years of testing and on-ground application have proven its effectiveness, affirming SuperCom’s overall approach of designing the suite to meet the unique needs of correctional facilities and law enforcement agencies worldwide.

This new order, valued at $3.4 million, builds on two prior orders from the Romanian government, totaling approximately $15.1 million. According to Ordan Trabelsi, President and CEO of SuperCom, “The recent order, valued at $3.4 million, underscores the caliber of our technology and the unwavering trust our clients have in SuperCom.”

When Romania kicked off its EM project, it looked to cover up to 15,000 enrollees simultaneously across the country. This would also include a unique integration of multiple offenders tracking sub-programs, goals which SuperCom helps them achieve. This latest order further stamps the company’s position as a market leader, offering superior, unrivaled products and services in the EM space.

“This latest order reinforces our status as a global frontrunner in electronic monitoring solutions. At SuperCom, we are dedicated to not only achieving excellent outcomes but also building enduring relationships with governments across the globe,” noted Mr. Trabelsi.

Deliveries are set to be met by the end of the fourth quarter of the 2023 calendar year. SuperCom’s management is optimistic that this order will help boost the company’s overall value proposition, allow for market expansion, and, most importantly, facilitate growth in shareholder value. Having stamped its status as a global frontrunner, the company’s management is confident that this order will lead to many more.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Generate Sizable License Revenue from IP Growth, Expanding Patent Suite

 

• Lexaria, a global innovator in drug delivery platforms, has, since 2014, continuously worked on its patented DehydraTECH(TM) drug delivery technology
• The technology has demonstrated overall effectiveness in enhanced delivery of fat-soluble molecules through the human gastrointestinal system, as affirmed by clinical testing
• This overall effectiveness and push for its development has earned Lexaria 37 granted patents globally, with many patents pending
• The company is constantly enhancing its patent portfolio, since granted patents can support an increase in licensing revenue

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is eyeing growth in license revenue from its intellectual property (“IP”). Since 2014, the company has continuously worked on its flagship technology – the patented DehydraTECH(TM) drug delivery technology – which has demonstrated the improvement of speed of onset, brain absorption, and bioavailability (https://ibn.fm/KSkD1). It is being investigated in association with dementia treatment, nicotine replacement, hypertension, and heart disease treatment, among other applications (https://ibn.fm/ItdVS).

So far, Lexaria has received 37 granted patents globally, with many patents pending. The company is aggressively pushing its patent application process as it recognizes the viable commercial application of its flagship technology. In addition, the company understands that successfully granted patents can lead to an increase in shareholder value as a recognized growing market leader.

“Because of the applicability of DehydraTECH to many market sectors across the globe, we have taken the necessary steps to protect that intellectual property internationally,” notes the company’s 2022 Form 10-K annual report (https://ibn.fm/xxsuF).

Lexaria’s patent portfolio currently spreads across the US, Australia, Japan, Mexico, the European Union, Canada and India. Its strategic approach of filing for applications in lucrative markets is a move to maximize potential revenue for years to come, mainly since out-licensing is a significant revenue stream for the company. DehydraTECH applications have shown that it can be applied in the consumer-packaged goods industry and the drug and pharmaceutical sectors. It has demonstrated suitability in various consumer formats such as oral suspensions, capsules, pills and tablets, nutraceuticals, registered drugs, and topical applications (https://ibn.fm/ZP6LI).

This is all made possible by DehydraTECH’s overall effectiveness in delivering most fat-soluble molecules through the human gastrointestinal system, as demonstrated by its overall effectiveness in crossing the blood-brain barrier once within blood plasma. Test data, both in vitro, in vivo, and human clinical testing, has shown that DehydraTECH reduces the time required to enter the bloodstream. It has also shown an increase in absorption rate, as well as the improvement of the taste and smell of edible products.

“Our current patent portfolio includes patent family applications or grants pertaining to our method of improving bioavailability and taste, and the use of DehydraTECH as a delivery platform for a wide variety of APIs including, but not limited to fat-soluble vitamins; anti-viral drugs; phosphodiesterase inhibitors; human hormones; regulated cannabinoids; and nicotine and its analogs,” notes Lexaria’s most recent Form 10-Q quarterly report (https://ibn.fm/A8THJ).

In June 2023, Lexaria received its latest two granted patents in Canada, bringing the total in the country to five. This followed the staggered receipts of three patents in the country in less than a year, a milestone that recognizes and protects the company’s improved compositions and methods for transdermal and dermal delivery of cannabinoids such as tetrahydrocannabinol (“THC”) and CBD. As it continues to push for more approvals, the company is steadily propping itself up for even more success, stamping its position as a leader in its space. More importantly, it is echoing its commitment to creating shareholder value.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Turbo Energy S.A. (NASDAQ: TURB) Is ‘One to Watch’

 

• Turbo Energy in September 2023 announced its successful debut on the Nasdaq stock exchange
• The company operates as a subsidiary of Umbrella Solar Investment S.A.
• Turbo Energy’s total revenue for the year ended December 31, 2022, increased by 82% year-over-year to €31,148,676 (approximately $33,321,219)
• In October 2023, the company was awarded a software patent in Spain related to its flagship Sunbox product

Turbo Energy (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.

Products

Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.

Inverters

The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

For more information, visit the company’s website at www.Turbo-e.com.

NOTE TO INVESTORS: The latest news and updates relating to TURB are available in the company’s newsroom at https://ibn.fm/TURB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

SenesTech Inc. (NASDAQ: SNES) Issues Q3 Report Amid Rollout of New Soft Bait Rodent Birth Control Formulation

 

• SenesTech Inc., a visionary leader in fertility control to manage animal pest populations, has developed products that show success in limiting rat populations using unique non-lethal fertility reduction products
• Rodents are often associated with carrying diseases that can affect humans, and SenesTech’s non-lethal population-reducing technology targets this major problem in a uniquely humane, environmentally conscious, yet effective way
• The Arizona-based company has developed two primary products — its liquid ContraPest(R) brand, and the recently introduced Evolve(TM) Soft Bait formulation, soft bait being favored by rodent control professionals
• The company anticipates using their technology to develop similar pest-control products for other species in the near future

Close on the heels of introducing a new product expected to create exponential revenue growth for the company, pest animal control innovator SenesTech (NASDAQ: SNES) reported its Q3 financial status to investors Nov. 9, highlighting the company’s continued progress in a year that has seen a record sequential quarterly increase in its earnings.

An archived recording of the Q3 report can be found on SenesTech’s Investor Relations page, at https://ibn.fm/AeEie.

SenesTech’s commitment to sustainable, non-toxic rodent reduction, is reflected in the company’s drive to market a global pest solution that introduces fertility control as the ideal alternative to toxic poisons.

Its trademarked liquid ContraPest(R) bait and Evolve(TM) Soft Bait both target the rapid birth rate in rodent populations, which can result in 15,000 offspring for a single pair of breeding rats in a year’s time and half a billion descendants within three years, according to research cited by President & CEO Joel Fruendt during an October webcast also available on the company’s archived recording webpage.

ContraPest established the company’s reputation with a brand that has shown success in reducing rat populations and subsequently increasing the profitability of poultry enterprises on both the East and West Coasts. The pest control industry’s preference for non-liquid applications then led SenesTech to formulate a non-liquid soft bait solution in its new Evolve product.

“Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest(R), but in a format that is easier to deploy and that they can use daily in their integrated pest management programs,” Fruendt stated in a Nov. 1 news release announcing that the company is now taking orders from commercial customers for the soft bait formulation (https://ibn.fm/guMGb).

“Evolve is also suited for use by consumers,” he added, “and we expect to announce partnerships with e-commerce providers and big box retailers by the end of the year.”

The company states that Evolve is highly palatable to rats, and can be placed virtually anywhere rats are found, ranging from outdoor parks and recreation facilities to medical facilities and residential locations.

Evolve currently is only formulated for rats, although the company expects to expand to other pest species in the near future. The product’s active ingredient is a compound derived from cottonseed oil administered in doses too low to affect other species’ fertility as long as the product isn’t consumed in substantial quantities over extended periods of time, but the company recommends using tamper-resistant bait stations to minimize potential non-target species exposure.

Evolve is designed for repeated application. Its non-lethal approach to rodent birth control anticipates a cumulative effect over time with a half-life of approximately three days after consumption, and the company states rats will regain their fertility within approximately six weeks after they stop consuming the bait.

With the advent of cooler weather in the Northern Hemisphere, rodent activity becomes more noticeable because of their efforts to find warm refuge. An estimated 21 million homes across the United States will be affected by rodent activity during the season, according to pest control corporation Orkin (https://ibn.fm/ASt6r).

SenesTech’s original liquid ContraPest brand has the benefit of targeting hard-to-get roof rodents, and is the only rat contraception product for both male and female rats registered with the Environmental Protection Agency (“EPA”).

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN